Oscar Gary Bukstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Central Nervous System Stimulants | 44 | 2020 | 1176 | 2.970 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 56 | 2020 | 3707 | 2.820 |
Why?
|
Methylphenidate | 26 | 2020 | 488 | 2.240 |
Why?
|
Substance-Related Disorders | 40 | 2020 | 4413 | 1.930 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 12 | 2020 | 306 | 1.920 |
Why?
|
Aggression | 13 | 2020 | 748 | 1.110 |
Why?
|
Alcohol-Related Disorders | 10 | 2013 | 238 | 1.040 |
Why?
|
Risperidone | 9 | 2017 | 381 | 0.890 |
Why?
|
Conduct Disorder | 9 | 2014 | 245 | 0.780 |
Why?
|
Alcoholism | 20 | 2018 | 1973 | 0.690 |
Why?
|
Delayed-Action Preparations | 10 | 2020 | 961 | 0.680 |
Why?
|
Psychotropic Drugs | 12 | 2018 | 885 | 0.660 |
Why?
|
Guanfacine | 4 | 2014 | 51 | 0.630 |
Why?
|
Adolescent Behavior | 9 | 2022 | 1188 | 0.620 |
Why?
|
Family Therapy | 3 | 2014 | 214 | 0.580 |
Why?
|
Mass Screening | 3 | 2022 | 5426 | 0.530 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 493 | 0.520 |
Why?
|
Mental Disorders | 18 | 2022 | 6823 | 0.510 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 2 | 2014 | 91 | 0.500 |
Why?
|
Parent-Child Relations | 2 | 2016 | 762 | 0.460 |
Why?
|
Suicide | 3 | 2022 | 1602 | 0.430 |
Why?
|
Adolescent | 84 | 2022 | 88300 | 0.430 |
Why?
|
Health Education | 3 | 2014 | 1049 | 0.390 |
Why?
|
School Health Services | 2 | 2013 | 384 | 0.390 |
Why?
|
Hydrocortisone | 2 | 2011 | 1818 | 0.390 |
Why?
|
Marijuana Abuse | 3 | 2012 | 410 | 0.380 |
Why?
|
Acetylcysteine | 1 | 2012 | 260 | 0.370 |
Why?
|
Child | 69 | 2022 | 80154 | 0.350 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2012 | 446 | 0.340 |
Why?
|
Adrenergic alpha-Agonists | 5 | 2011 | 177 | 0.340 |
Why?
|
Personality | 1 | 2013 | 553 | 0.340 |
Why?
|
Fluoxetine | 8 | 2011 | 728 | 0.320 |
Why?
|
Testosterone | 2 | 2011 | 2472 | 0.320 |
Why?
|
Androstenedione | 1 | 2009 | 131 | 0.320 |
Why?
|
Personality Assessment | 7 | 2008 | 649 | 0.310 |
Why?
|
Parents | 15 | 2017 | 3564 | 0.300 |
Why?
|
Saliva | 2 | 2011 | 828 | 0.300 |
Why?
|
Comorbidity | 27 | 2019 | 10516 | 0.290 |
Why?
|
Substance Abuse Detection | 2 | 2008 | 301 | 0.290 |
Why?
|
Dehydroepiandrosterone | 1 | 2009 | 258 | 0.290 |
Why?
|
Referral and Consultation | 2 | 2020 | 3608 | 0.290 |
Why?
|
Alcohol Drinking | 6 | 2013 | 4027 | 0.280 |
Why?
|
Child Behavior | 1 | 2022 | 848 | 0.270 |
Why?
|
Depressive Disorder, Major | 12 | 2022 | 4767 | 0.270 |
Why?
|
Diagnosis, Dual (Psychiatry) | 8 | 2009 | 303 | 0.250 |
Why?
|
Psychiatric Status Rating Scales | 14 | 2020 | 6011 | 0.250 |
Why?
|
Membrane Lipids | 1 | 2006 | 251 | 0.250 |
Why?
|
Psychiatry | 1 | 2017 | 1699 | 0.250 |
Why?
|
Humans | 131 | 2022 | 761222 | 0.230 |
Why?
|
Depression | 2 | 2022 | 8132 | 0.220 |
Why?
|
Double-Blind Method | 21 | 2020 | 12341 | 0.220 |
Why?
|
Basal Ganglia | 1 | 2006 | 554 | 0.220 |
Why?
|
Clonidine | 3 | 2009 | 168 | 0.220 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2020 | 10756 | 0.210 |
Why?
|
Phospholipids | 1 | 2006 | 784 | 0.210 |
Why?
|
Antipsychotic Agents | 7 | 2017 | 3064 | 0.200 |
Why?
|
Antidepressive Agents | 5 | 2022 | 2893 | 0.200 |
Why?
|
Psychotherapy | 10 | 2022 | 1646 | 0.200 |
Why?
|
Drug Administration Schedule | 8 | 2020 | 4851 | 0.180 |
Why?
|
Practice Guidelines as Topic | 4 | 2018 | 7400 | 0.180 |
Why?
|
Male | 83 | 2020 | 360703 | 0.180 |
Why?
|
Telemedicine | 1 | 2017 | 3051 | 0.170 |
Why?
|
Prefrontal Cortex | 2 | 2008 | 2219 | 0.170 |
Why?
|
Mood Disorders | 4 | 2020 | 1124 | 0.170 |
Why?
|
Dysthymic Disorder | 2 | 2009 | 75 | 0.170 |
Why?
|
Drug Therapy, Combination | 12 | 2017 | 6304 | 0.170 |
Why?
|
Behavior Therapy | 4 | 2010 | 875 | 0.170 |
Why?
|
Female | 79 | 2020 | 392552 | 0.160 |
Why?
|
Temporal Lobe | 1 | 2006 | 1695 | 0.160 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 8 | 2020 | 1990 | 0.160 |
Why?
|
Antidepressive Agents, Second-Generation | 3 | 2010 | 489 | 0.160 |
Why?
|
Bipolar Disorder | 4 | 2014 | 5092 | 0.160 |
Why?
|
Treatment Outcome | 35 | 2022 | 64681 | 0.160 |
Why?
|
Sex Characteristics | 1 | 2009 | 2640 | 0.150 |
Why?
|
Mental Health | 1 | 2022 | 3251 | 0.150 |
Why?
|
Pennsylvania | 9 | 2009 | 612 | 0.140 |
Why?
|
Violence | 2 | 2022 | 935 | 0.140 |
Why?
|
Combined Modality Therapy | 15 | 2017 | 8519 | 0.140 |
Why?
|
Affective Symptoms | 1 | 2020 | 417 | 0.140 |
Why?
|
Age of Onset | 4 | 2014 | 3307 | 0.140 |
Why?
|
Interview, Psychological | 5 | 2011 | 809 | 0.140 |
Why?
|
Analysis of Variance | 5 | 2016 | 6223 | 0.140 |
Why?
|
Phosphorus | 2 | 2008 | 332 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3770 | 0.130 |
Why?
|
Child Psychiatry | 2 | 2009 | 227 | 0.130 |
Why?
|
Dyslexia | 1 | 2017 | 208 | 0.120 |
Why?
|
Anxiety Disorders | 5 | 2020 | 2723 | 0.120 |
Why?
|
Patient Satisfaction | 3 | 2016 | 3453 | 0.120 |
Why?
|
Risk Factors | 14 | 2022 | 74241 | 0.120 |
Why?
|
Achievement | 1 | 2016 | 288 | 0.120 |
Why?
|
Administration, Cutaneous | 4 | 2009 | 713 | 0.120 |
Why?
|
Data Interpretation, Statistical | 1 | 2004 | 2691 | 0.120 |
Why?
|
Peer Group | 4 | 2014 | 691 | 0.120 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5333 | 0.110 |
Why?
|
Forensic Psychiatry | 2 | 2011 | 196 | 0.110 |
Why?
|
Psychometrics | 5 | 2020 | 3061 | 0.110 |
Why?
|
Fathers | 1 | 2016 | 375 | 0.110 |
Why?
|
Depressive Disorder | 7 | 2004 | 3727 | 0.110 |
Why?
|
Personality Development | 2 | 1991 | 243 | 0.110 |
Why?
|
Reading | 1 | 2017 | 531 | 0.110 |
Why?
|
Child Abuse | 2 | 2011 | 1076 | 0.110 |
Why?
|
Cross-Over Studies | 7 | 2020 | 2082 | 0.100 |
Why?
|
Socialization | 1 | 1993 | 87 | 0.100 |
Why?
|
Patient Acceptance of Health Care | 2 | 2011 | 3200 | 0.100 |
Why?
|
Social Perception | 1 | 2016 | 431 | 0.100 |
Why?
|
Child Custody | 1 | 2011 | 20 | 0.100 |
Why?
|
Internal-External Control | 1 | 2014 | 358 | 0.100 |
Why?
|
Child of Impaired Parents | 4 | 1992 | 460 | 0.100 |
Why?
|
Child Behavior Disorders | 5 | 2008 | 804 | 0.090 |
Why?
|
Suicide, Attempted | 3 | 2009 | 1402 | 0.090 |
Why?
|
Juvenile Delinquency | 1 | 2011 | 116 | 0.090 |
Why?
|
Cognition Disorders | 3 | 2012 | 3976 | 0.090 |
Why?
|
Severity of Illness Index | 13 | 2020 | 15841 | 0.090 |
Why?
|
Urban Population | 1 | 1998 | 2036 | 0.090 |
Why?
|
Motivation | 3 | 2011 | 2002 | 0.090 |
Why?
|
Adolescent Psychiatry | 2 | 2009 | 156 | 0.080 |
Why?
|
Prevalence | 7 | 2009 | 15721 | 0.080 |
Why?
|
Expert Testimony | 1 | 2011 | 365 | 0.080 |
Why?
|
Psychology | 2 | 2009 | 356 | 0.080 |
Why?
|
Ganglia | 1 | 2008 | 86 | 0.080 |
Why?
|
Hospitals, Psychiatric | 3 | 2002 | 318 | 0.080 |
Why?
|
Affect | 1 | 2016 | 1486 | 0.080 |
Why?
|
Parenting | 2 | 2014 | 701 | 0.080 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 600 | 0.080 |
Why?
|
Critical Pathways | 2 | 2001 | 475 | 0.070 |
Why?
|
Treatment Refusal | 1 | 2011 | 430 | 0.070 |
Why?
|
Alcohol Deterrents | 2 | 2005 | 49 | 0.070 |
Why?
|
Drug Synergism | 4 | 2016 | 1756 | 0.070 |
Why?
|
Family | 4 | 2009 | 3192 | 0.070 |
Why?
|
Malpractice | 1 | 2011 | 553 | 0.070 |
Why?
|
Social Behavior | 4 | 2015 | 1136 | 0.070 |
Why?
|
Ethics, Medical | 1 | 2011 | 785 | 0.070 |
Why?
|
Sexuality | 1 | 2008 | 180 | 0.070 |
Why?
|
Bupropion | 1 | 2008 | 304 | 0.070 |
Why?
|
Community Mental Health Services | 1 | 2009 | 387 | 0.060 |
Why?
|
Schools | 2 | 2008 | 1483 | 0.060 |
Why?
|
Mothers | 1 | 2016 | 2193 | 0.060 |
Why?
|
Renal Agents | 1 | 2004 | 30 | 0.060 |
Why?
|
Alcohol-Induced Disorders | 1 | 2005 | 27 | 0.060 |
Why?
|
Enuresis | 1 | 2004 | 50 | 0.060 |
Why?
|
Self Report | 1 | 2016 | 3727 | 0.060 |
Why?
|
Deamino Arginine Vasopressin | 1 | 2004 | 87 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2009 | 1186 | 0.060 |
Why?
|
Crisis Intervention | 2 | 2002 | 109 | 0.060 |
Why?
|
Medication Adherence | 2 | 2016 | 2175 | 0.050 |
Why?
|
Adult | 18 | 2017 | 221120 | 0.050 |
Why?
|
Emergency Services, Psychiatric | 1 | 2003 | 63 | 0.050 |
Why?
|
Restraint, Physical | 2 | 2002 | 185 | 0.050 |
Why?
|
Neuropsychological Tests | 2 | 2020 | 7046 | 0.050 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 934 | 0.050 |
Why?
|
Personality Inventory | 3 | 2009 | 1018 | 0.050 |
Why?
|
Follow-Up Studies | 12 | 2017 | 39127 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6988 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1432 | 0.050 |
Why?
|
Substance Abuse Treatment Centers | 3 | 2004 | 166 | 0.050 |
Why?
|
Sex Factors | 5 | 2008 | 10553 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3803 | 0.050 |
Why?
|
Young Adult | 5 | 2022 | 59222 | 0.050 |
Why?
|
Program Development | 1 | 2008 | 1294 | 0.050 |
Why?
|
Patient Isolation | 1 | 2001 | 100 | 0.050 |
Why?
|
Reference Values | 2 | 2005 | 4921 | 0.050 |
Why?
|
Drug Delivery Systems | 2 | 2009 | 2223 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 1991 | 2632 | 0.040 |
Why?
|
Placebos | 3 | 2011 | 1666 | 0.040 |
Why?
|
Residential Treatment | 1 | 2000 | 111 | 0.040 |
Why?
|
Cross-Sectional Studies | 8 | 2008 | 26072 | 0.040 |
Why?
|
Risk-Taking | 1 | 2005 | 1038 | 0.040 |
Why?
|
Evidence-Based Medicine | 3 | 2007 | 3691 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2004 | 1381 | 0.040 |
Why?
|
Demography | 1 | 2004 | 1641 | 0.040 |
Why?
|
Electroconvulsive Therapy | 1 | 2004 | 498 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2569 | 0.040 |
Why?
|
Time Factors | 6 | 2017 | 39957 | 0.040 |
Why?
|
Social Environment | 2 | 2008 | 1022 | 0.040 |
Why?
|
Research | 1 | 2007 | 1976 | 0.040 |
Why?
|
Health Personnel | 1 | 2022 | 3337 | 0.040 |
Why?
|
Alcoholic Intoxication | 3 | 2005 | 174 | 0.040 |
Why?
|
Data Collection | 2 | 2004 | 3320 | 0.040 |
Why?
|
Psychological Techniques | 1 | 2018 | 48 | 0.040 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 1999 | 1492 | 0.040 |
Why?
|
Drug Utilization | 1 | 2003 | 1188 | 0.040 |
Why?
|
Patient Compliance | 3 | 2017 | 2688 | 0.040 |
Why?
|
Synapses | 1 | 2006 | 1755 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2013 | 1577 | 0.030 |
Why?
|
Prognosis | 3 | 2008 | 29688 | 0.030 |
Why?
|
Child, Preschool | 5 | 2022 | 42225 | 0.030 |
Why?
|
Individuality | 2 | 2001 | 303 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2008 | 10218 | 0.030 |
Why?
|
Primary Health Care | 1 | 2022 | 4679 | 0.030 |
Why?
|
United States | 10 | 2018 | 72341 | 0.030 |
Why?
|
Wounds and Injuries | 2 | 2005 | 2493 | 0.030 |
Why?
|
Serotonin | 1 | 2020 | 1042 | 0.030 |
Why?
|
Age Factors | 3 | 2008 | 18384 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2010 | 4575 | 0.030 |
Why?
|
Nerve Net | 1 | 2006 | 2288 | 0.030 |
Why?
|
Electrocardiography | 1 | 2008 | 6387 | 0.030 |
Why?
|
Patient Care Management | 1 | 2018 | 303 | 0.030 |
Why?
|
Impulsive Behavior | 1 | 2017 | 346 | 0.030 |
Why?
|
Sleep | 2 | 2008 | 4759 | 0.030 |
Why?
|
Clonazepam | 1 | 1994 | 135 | 0.030 |
Why?
|
Perceptual Distortion | 1 | 1994 | 36 | 0.030 |
Why?
|
Defense Mechanisms | 1 | 1994 | 180 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 8002 | 0.030 |
Why?
|
Secondary Prevention | 2 | 2009 | 1472 | 0.030 |
Why?
|
Stereotyped Behavior | 1 | 2013 | 135 | 0.030 |
Why?
|
Behavioral Symptoms | 1 | 2014 | 186 | 0.030 |
Why?
|
Social Adjustment | 2 | 1994 | 632 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1510 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2014 | 5250 | 0.020 |
Why?
|
Patient Dropouts | 1 | 1992 | 411 | 0.020 |
Why?
|
Hospitalization | 4 | 1994 | 10707 | 0.020 |
Why?
|
Administration, Oral | 2 | 2010 | 4015 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2016 | 982 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 12976 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2009 | 7865 | 0.020 |
Why?
|
Recreation | 1 | 2009 | 125 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2125 | 0.020 |
Why?
|
Life Change Events | 1 | 1993 | 952 | 0.020 |
Why?
|
Temperament | 1 | 1990 | 297 | 0.020 |
Why?
|
Observer Variation | 2 | 2007 | 2610 | 0.020 |
Why?
|
Erythema | 1 | 2009 | 262 | 0.020 |
Why?
|
Patient Admission | 1 | 1995 | 1365 | 0.020 |
Why?
|
Control Groups | 1 | 2008 | 104 | 0.020 |
Why?
|
Case Management | 1 | 2009 | 272 | 0.020 |
Why?
|
Learning | 1 | 2017 | 1737 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2007 | 22174 | 0.020 |
Why?
|
Confidentiality | 1 | 2011 | 605 | 0.020 |
Why?
|
Neurons | 1 | 2006 | 9429 | 0.020 |
Why?
|
Behavior, Addictive | 1 | 1993 | 462 | 0.020 |
Why?
|
Propylamines | 1 | 2007 | 161 | 0.020 |
Why?
|
Self Concept | 1 | 1993 | 1046 | 0.020 |
Why?
|
Self Efficacy | 1 | 2011 | 636 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17897 | 0.020 |
Why?
|
Incidence | 3 | 1995 | 21366 | 0.020 |
Why?
|
Bradycardia | 1 | 2008 | 298 | 0.020 |
Why?
|
Firearms | 1 | 1993 | 626 | 0.020 |
Why?
|
Osmosis | 1 | 2006 | 103 | 0.020 |
Why?
|
Prodrugs | 1 | 2007 | 262 | 0.020 |
Why?
|
Anorexia | 1 | 2006 | 152 | 0.020 |
Why?
|
Personality Disorders | 1 | 1990 | 719 | 0.020 |
Why?
|
Tachycardia | 1 | 2008 | 599 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 1993 | 1437 | 0.020 |
Why?
|
Educational Status | 2 | 2008 | 2510 | 0.020 |
Why?
|
Physician's Role | 1 | 2011 | 920 | 0.010 |
Why?
|
Family Health | 1 | 2009 | 1254 | 0.010 |
Why?
|
Education | 1 | 2007 | 536 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1336 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2317 | 0.010 |
Why?
|
Sleep Stages | 1 | 2008 | 695 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2005 | 367 | 0.010 |
Why?
|
Drug Resistance | 1 | 2009 | 1594 | 0.010 |
Why?
|
Long QT Syndrome | 1 | 2008 | 466 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2008 | 645 | 0.010 |
Why?
|
Pilot Projects | 2 | 2008 | 8642 | 0.010 |
Why?
|
Drug Interactions | 1 | 2008 | 1417 | 0.010 |
Why?
|
Brazil | 1 | 2007 | 1228 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2003 | 284 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2004 | 641 | 0.010 |
Why?
|
Pemoline | 1 | 2002 | 18 | 0.010 |
Why?
|
Recurrence | 2 | 2005 | 8457 | 0.010 |
Why?
|
Functional Laterality | 1 | 2008 | 2257 | 0.010 |
Why?
|
Health Status | 1 | 1995 | 4077 | 0.010 |
Why?
|
Regression Analysis | 2 | 2001 | 6345 | 0.010 |
Why?
|
Hospitals, University | 1 | 2003 | 565 | 0.010 |
Why?
|
Amphetamines | 1 | 2002 | 143 | 0.010 |
Why?
|
Prospective Studies | 3 | 2010 | 54437 | 0.010 |
Why?
|
Tics | 1 | 2001 | 74 | 0.010 |
Why?
|
Social Support | 1 | 2011 | 2175 | 0.010 |
Why?
|
Benzhydryl Compounds | 1 | 2007 | 917 | 0.010 |
Why?
|
Psychopharmacology | 1 | 2002 | 145 | 0.010 |
Why?
|
Counseling | 1 | 2008 | 1536 | 0.010 |
Why?
|
Child Day Care Centers | 1 | 2000 | 122 | 0.010 |
Why?
|
Appetite | 1 | 2001 | 247 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5869 | 0.010 |
Why?
|
Patient Advocacy | 1 | 2001 | 358 | 0.010 |
Why?
|
Program Evaluation | 1 | 2008 | 2489 | 0.010 |
Why?
|
Narcolepsy | 1 | 2002 | 199 | 0.010 |
Why?
|
Social Isolation | 1 | 2002 | 365 | 0.010 |
Why?
|
Emergencies | 1 | 2005 | 1217 | 0.010 |
Why?
|
Acute Disease | 1 | 2009 | 7226 | 0.010 |
Why?
|
Headache | 1 | 2006 | 1255 | 0.010 |
Why?
|
Algorithms | 2 | 2009 | 14025 | 0.010 |
Why?
|
Models, Psychological | 1 | 2002 | 830 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2007 | 2019 | 0.010 |
Why?
|
Students | 1 | 2008 | 1737 | 0.010 |
Why?
|
Psychotic Disorders | 2 | 2007 | 3220 | 0.010 |
Why?
|
North America | 1 | 2001 | 1284 | 0.010 |
Why?
|
Quality of Life | 2 | 2009 | 13367 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2004 | 2697 | 0.010 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2006 | 1081 | 0.010 |
Why?
|
History, 20th Century | 1 | 2004 | 2765 | 0.010 |
Why?
|
Heart Rate | 1 | 2008 | 4197 | 0.010 |
Why?
|
Logistic Models | 2 | 2003 | 13249 | 0.010 |
Why?
|
South Australia | 1 | 1995 | 26 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2002 | 961 | 0.010 |
Why?
|
Brain | 1 | 2002 | 27094 | 0.010 |
Why?
|
Thioridazine | 1 | 1994 | 33 | 0.010 |
Why?
|
Clomipramine | 1 | 1994 | 54 | 0.010 |
Why?
|
Weight Loss | 1 | 2006 | 2680 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1991 | 14610 | 0.010 |
Why?
|
Chronic Disease | 1 | 2009 | 9319 | 0.010 |
Why?
|
Utilization Review | 1 | 1995 | 382 | 0.010 |
Why?
|
Diazepam | 1 | 1994 | 215 | 0.010 |
Why?
|
Liver Function Tests | 1 | 1995 | 525 | 0.010 |
Why?
|
Phobic Disorders | 1 | 1995 | 439 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 3418 | 0.010 |
Why?
|
Cluster Analysis | 1 | 1997 | 2706 | 0.010 |
Why?
|
Adjustment Disorders | 1 | 1990 | 67 | 0.010 |
Why?
|
Culture | 1 | 1993 | 623 | 0.000 |
Why?
|
Survival Analysis | 1 | 2001 | 10088 | 0.000 |
Why?
|
Odds Ratio | 1 | 1997 | 9652 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1992 | 80675 | 0.000 |
Why?
|
Health Behavior | 1 | 1995 | 2641 | 0.000 |
Why?
|
Borderline Personality Disorder | 1 | 1990 | 766 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2000 | 20118 | 0.000 |
Why?
|
Patient Readmission | 1 | 1995 | 3265 | 0.000 |
Why?
|
Length of Stay | 1 | 1992 | 6417 | 0.000 |
Why?
|
Smoking | 1 | 1995 | 9055 | 0.000 |
Why?
|